Community Acquired Infection of unknown focus in Infants and Children ( not on NICU ) - Management of |
Publication: 28/11/2011 |
Next review: 22/11/2024 |
Clinical Guideline |
CURRENT |
ID: 2671 |
Approved By: Improving Antimicrobial Prescribing Group |
Copyright© Leeds Teaching Hospitals NHS Trust 2017 |
This Clinical Guideline is intended for use by healthcare professionals within Leeds unless otherwise stated. |
Management of community-acquired infection of unknown focus in Infants and Children between 4 weeks and 16 years old (not on NICU)
Summary Community Acquired Infection of unknown focus in Infants and Children ( not on NICU ) |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Management Pathway Flowchart/ Overview Inclusion criteria:
Action: Record weight, observations, PAWS and enter pathway corresponding to history, examination and PAWS score
Other considerations for admission In addition to the child's clinical condition, consider the following factors when deciding whether to admit a child with fever to hospital:
Specific Conditions
Final Common Pathway
Discharged at time__________ Follow-up. Follow-up for pyrexia of unknown origin depends on final diagnosis and should be discussed with the Consultant. All Children with proven or suspected bacterial meningitis should have a hearing check within 4 weeks arranged and follow-up with the results with Children’s Medicine. Consider additional follow-up with appropriate specialities based on co-morbidities. HV and or school nurse should be informed. 4.6. Children with a second episode of meningitis, meningococcal non group-B serotypes, or who have a history of recurrent bacterial infection should be considered by the consultant for immune testing. In addition those with meningococcal disease with a FH of meningococcal disease or complement deficiency |
Treatment |
Non-Antimicrobial Treatment |
Recommendation: This should proceed as standard Paediatric Life Support (APLS, EPLS, PLS) training. [Evidence level C] Identifying & treating :-
One should have a low threshold for securing additional expert assistance Paediatric CRASH 2222 |
Empirical Antimicrobial Treatment |
Recommendation: Neonates (under 1 month) with suspected severe infection but no clinically obvious focus should be empirically treated with a combination of Benzylpenicillin Recommendation: In children 1-3 months old with suspected severe infection (red features) but no clinically obvious focus of infection Cefotaxime Recommendation: In children over 3 months old with a fever and evidence of severe infection (red features) but no clinically obvious focus of infection ceftriaxone is advised 1 [Evidence level C] Recommendation: Empirical antimicrobial regimens should be reviewed with microbiology results and stopped or amended accordingly. [Evidence level C] |
Directed Antimicrobial Treatment (when microbiology results are known) |
Recommendation: Empirical antimicrobial regimens should be reviewed with microbiology results and stopped or amended accordingly. [Evidence level C] Recommendation: If a specific pathogen or source of infection is identified as a result of clinical assessment, a period of observation or investigations, therapy should be amended appropriately and relevant treatment guidelines/pathways followed. [Evidence level D] Specific antimicrobial advice regarding directed treatment is outside the scope of this guideline. Many episodes of feverish illness in children are treated as suspected sepsis- awaiting negative microbiological results to safely discontinue empiric antimicrobials. This highlights the importance of blood culture sampling- to permit a decision regarding discontinuing or continuing antimicrobials empirically. The decision to discontinue antimicrobials is at the discretion of the on-call Consultant, and is usually made 36-48 hours after cultures were taken, in the light of microbiological (culture, PCR) and other investigations (Chest x-ray) and the clinical condition of the child. |
Duration of Treatment |
Recommendation: All prescriptions for antibiotics should be reviewed on a daily basis in conjunction with a clinical assessment and results of investigations. [Evidence base C] |
Switch to oral agent(s) |
This guideline concerns the initial management of suspected infection, switch to oral agents will depend upon the final clinical diagnosis and consultation with appropriate guidelines is advised. |
Treatment Failure |
Recommendation: Treatment failure should be understood as:
Clinical deterioration should be managed as from the summary of this document, & mandates notification of the on-call consultant. |
Provenance
Record: | 2671 |
Objective: | Aim
Objectives
|
Clinical condition: | Sepsis of unknown origin |
Target patient group: | Children with sepsis of unknown origin |
Target professional group(s): | Secondary Care Doctors |
Adapted from: |
Evidence base
References
- NICE. Feverish Illness in children: the assessment and initial management in children younger than 5 years: National Institute for Health and Clinical Excellence, 2007. (replaced by CG10 May 2013)
- Metsvaht T, Ilmoja ML, Parm U, Maipuu L, Merila M, Lutsar I. Comparison of ampicillin plus gentamicin vs. penicillin plus gentamicin in empiric treatment of neonates at risk of early onset sepsis. Acta Paediatr 2010;99(5):665-72.
- Muller-Pebody B, Johnson AP, Heath PT, Gilbert RE, Henderson KL, Sharland M. Empirical treatment of neonatal sepsis: are the current guidelines adequate? Arch Dis Child Fetal Neonatal Ed 2011;96(1):F4-8.
- Clark RH, Bloom BT, Spitzer AR, Gerstmann DR. Empiric use of ampicillin and cefotaxime, compared with ampicillin and gentamicin, for neonates at risk for sepsis is associated with an increased risk of neonatal death. Pediatrics 2006;117(1):67-74.
Evidence levels:
A. Meta-analyses, randomised controlled trials/systematic reviews of RCTs
B. Robust experimental or observational studies
C. Expert consensus.
D. Leeds consensus. (where no national guidance exists or there is wide disagreement with a level C recommendation or where national guidance documents contradict each other)
Approved By
Improving Antimicrobial Prescribing Group
Document history
LHP version 1.0
Related information
Not supplied
Equity and Diversity
The Leeds Teaching Hospitals NHS Trust is committed to ensuring that the way that we provide services and the way we recruit and treat staff reflects individual needs, promotes equality and does not discriminate unfairly against any particular individual or group.